Search

Your search keyword '"Tybjaerg-Hansen, Anne"' showing total 470 results

Search Constraints

Start Over You searched for: Author "Tybjaerg-Hansen, Anne" Remove constraint Author: "Tybjaerg-Hansen, Anne" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
470 results on '"Tybjaerg-Hansen, Anne"'

Search Results

2. Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis

5. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

7. Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis

10. Stroke genetics informs drug discovery and risk prediction across ancestries

12. New insights into the genetic etiology of Alzheimer’s disease and related dementias

13. ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma

14. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

21. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

24. Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?

26. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

28. Polygenic risk scores for cardiovascular risk prediction: moving towards implementation into clinical practice?

31. Neutrophil counts and cardiovascular disease.

32. Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life.

33. Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society.

34. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes

35. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

38. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

40. Genetic risk of fatty liver disease and mortality in the general population: A Mendelian randomization study.

41. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

42. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

43. Triglyceride-rich remnant lipoproteins are more atherogenic than LDL per particle: is this important?

46. Secretory Phospholipase A2-IIA and Cardiovascular Disease: A Mendelian Randomization Study

50. Rare and low-frequency coding variants alter human adult height

Catalog

Books, media, physical & digital resources